| For: | Shao JW, Ge TT, Chen SZ, Wang G, Yang Q, Huang CH, Xu LC, Chen Z. Role of bile acids in liver diseases mediated by the gut microbiome. World J Gastroenterol 2021; 27(22): 3010-3021 [PMID: 34168404 DOI: 10.3748/wjg.v27.i22.3010] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i22/3010.htm |
| Number | Citing Articles |
| 1 |
Yi Zhen Han, Hui Juan Zheng, Bo Xuan Du, Yi Zhang, Xing Yu Zhu, Jing Li, Yao Xian Wang, Wei Jing Liu, Balamurugan Ramatchandirin. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease. Journal of Diabetes Research 2023; 2023 doi: 10.1155/2023/8871677
|
| 2 |
Smaragda Ntona, Apostolis Papaefthymiou, Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis, Marina Boziki, Stergios A. Polyzos, Maria Tzitiridou, Dimitrios Chatzopoulos, Tharshika Thavayogarajah, Ioanna Gkolia, Georgios Ntonas, Elisabeth Vardaka, Michael Doulberis. Impact of nonalcoholic fatty liver disease-related metabolic state on depression. Neurochemistry International 2023; 163 doi: 10.1016/j.neuint.2023.105484
|
| 3 |
Fuchang Deng, Guangqiu Qin, Yuanyuan Chen, Xu Zhang, Mu Zhu, Min Hou, Qiao Yao, Wen Gu, Chao Wang, Hui Yang, Xudong Jia, Chongming Wu, Hui Peng, Huamao Du, Song Tang. Multi-omics reveals 2-bromo-4,6-dinitroaniline (BDNA)-induced hepatotoxicity and the role of the gut-liver axis in rats. Journal of Hazardous Materials 2023; 457 doi: 10.1016/j.jhazmat.2023.131760
|
| 4 |
Nasreen Nazar, A. S. Athira, Ranjit Kumar Nadella, Satyen Kumar Panda, Kaushik Banerjee, Niladri Sekhar Chatterjee. Untargeted metabolomics offers insights into the risks of chronic exposure to mixtures of polycyclic aromatic hydrocarbons at environmentally relevant low concentrations. Environmental Geochemistry and Health 2025; 47(6) doi: 10.1007/s10653-025-02547-0
|
| 5 |
Shuqin Lin, Yunjuan Xiao, Siyu Li, Liyan Tang, Haitao Shi, Meiling Hong, Li Ding. Thiacloprid exposure disrupts the gut-liver axis and induces liver dysfunction in the Reeves' turtles (Mauremys reevesii). Ecotoxicology and Environmental Safety 2025; 289 doi: 10.1016/j.ecoenv.2025.117710
|
| 6 |
Yiming Ni, Mengna Lu, Yuan Xu, Qixue Wang, Xinyi Gu, Ying Li, Tongxi Zhuang, Chenyi Xia, Ting Zhang, Xiao-jun Gou, Mingmei Zhou. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.908011
|
| 7 |
Ming-Yu Jin, Xiao-Yong Wu, Mei-Ying Li, Hao Deng, Ri-Ming Huang, Yuan-Ming Sun, Cheol-Heui Yun, Zhen-Lin Xu. Noni (Morinda citrifolia L.) Fruit Polysaccharide Attenuated Inflammatory Bowel Disease Mice: Association of STAT3/NLRP3 Signaling Pathways. ACS Food Science & Technology 2023; 3(11) doi: 10.1021/acsfoodscitech.3c00351
|
| 8 |
Chang Sun, Xing Zhou, Ting Guo, Jia Meng. The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1168818
|
| 9 |
Huiji Pan, Meiling Zhou, Zhao Ju, Jinhua Luo, Jing Jin, Liangfang Shen, Pingkun Zhou, Ruixue Huang. Potential role of gut microbiota-LCA-INSR axis in high fat-diet-induced non-alcoholic fatty liver dysfunction: From perspective of radiation variation. Current Research in Food Science 2022; 5 doi: 10.1016/j.crfs.2022.09.022
|
| 10 |
Liming Liu, Liquan Deng, Wei Wei, Chunhua Li, Yuting Lu, Jieying Bai, Letian Li, Heping Zhang, Ningyi Jin, Chang Li, Cuiqing Zhao. Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice. International Journal of Molecular Sciences 2023; 24(18) doi: 10.3390/ijms241813997
|
| 11 |
Basira Mir-Makhamad, Daniel Giddings Vassão, Denya Arbach-Benz, Mohammad Javad Shoaee, Li Tang, Noel Amano, Yoko Nakamura, Christian Paetz, Abdallah Mohamed Nganyalila, Aloyce Mwambwiga, Meshack Kingi, Julio Mercader, Hamed Vahdati Nasab, Hongliang Lu, Robert Spengler, Thomas Larsen, Yiming V. Wang. Regional variability in faecal bile acids and its implications for species identification in archaeology. Archaeological and Anthropological Sciences 2026; 18(6) doi: 10.1007/s12520-026-02490-w
|
| 12 |
Dorna Hashemi, Mohammad Vahedi Fard, Kimia Mohammadhasani, Mehdi Barati, Elyas Nattagh‐Eshtivani. Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review. Food Science & Nutrition 2025; 13(3) doi: 10.1002/fsn3.70092
|
| 13 |
Tingting Zhao, Xi Zhang, Qian Xiang, Yadi Liu, Xuling Li, Junling Gu, Wenqian Zhang, Zhe Wang, Yiran Li, Xiaoshan Lai, Yonghua Zhao, Youhua Xu. Sodium Butyrate Ameliorated Bile Acid Metabolism in Diabetes Mellitus by PI3K/AKT Signaling Pathway via the Gut–Liver Axis. Current Issues in Molecular Biology 2025; 47(9) doi: 10.3390/cimb47090732
|
| 14 |
Hui Yan, Guige Xu, Lei Bei, Shijin Jiang, Ruihua Zhang. Duck hepatitis A virus type 1 infection induces hepatic metabolite and gut microbiota changes in ducklings. Poultry Science 2024; 103(2) doi: 10.1016/j.psj.2023.103265
|
| 15 |
Arthur D Stem, Ricardo Scheufen Tieghi, Vaia Lida Chatzi, Nicole Kleinstreuer, Damaskini Valvi, David C Thompson, Vasilis Vasiliou. Synergistic toxicity in alcohol-associated liver disease and PFAS exposure. Toxicological Sciences 2025; 208(1) doi: 10.1093/toxsci/kfaf110
|
| 16 |
Yang Bao, Xiao Han, Da Liu, Zhaolin Tan, Yongzhi Deng. Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine – a case study of diabetes and nonalcoholic fatty liver disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1072376
|
| 17 |
Vlad Răzniceanu, Andra Țichindeleanu, Eugen-Valentin Răducu, Șerban Ellias Trella, Iuliana Nenu. Gut dysbiosis and nitric oxide dysregulation in cirrhosis progression: mechanistic insights and pathophysiological implications. Journal of Physiology and Biochemistry 2026; 82(1) doi: 10.1007/s13105-026-01188-w
|
| 18 |
Nahum Mendez-Sanchez, Carlos Esteban Coronel-Castillo, Jacqueline Cordova-Gallardo, Xingshun Qi. Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota. Antibiotics 2023; 12(10) doi: 10.3390/antibiotics12101475
|
| 19 |
Chang Sun, Chenguang Qiu, Yanyan Zhang, Man Yan, Jiajun Tan, Jiayuan He, Dakai Yang, Dongxu Wang, Liang Wu. Lactiplantibacillus plantarum NKK20 Alleviates High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Regulating Bile Acid Anabolism. Molecules 2023; 28(10) doi: 10.3390/molecules28104042
|
| 20 |
Koichi Sudo, Amber Delmas-Eliason, Shannon Soucy, Kaitlyn E. Barrack, Jiabao Liu, Akshaya Balasubramanian, Chengyi Jenny Shu, Michael J. James, Courtney L. Hegner, Henry D. Dionne, Alex Rodriguez-Palacios, Henry M. Krause, George A. O’Toole, Saul J. Karpen, Paul A. Dawson, Daniel Schultz, Mark S. Sundrud. Quantifying Forms and Functions of Enterohepatic Bile Acid Pools in Mice. Cellular and Molecular Gastroenterology and Hepatology 2024; 18(6) doi: 10.1016/j.jcmgh.2024.101392
|
| 21 |
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525
|
| 22 |
Arthur D. Stem, Mohammad Alayyoub, Reza Aalizadeh, Varvara Nikolopoulou, Athina Lisgara, Ava Shvartsman, Mallappa Anitha, Andrew Patterson, Rachel Coble, Blake Rushing, Susan Sumner, Vasilis Vasiliou. Integrated Multi-Omics Reveals Synergistic Hepatotoxicity of Ethanol and PFOS Co-Exposure. Chemico-Biological Interactions 2026; 434 doi: 10.1016/j.cbi.2026.112101
|
| 23 |
Hao Zhang, Tingting Ni, Xia Zha, Mabrouk Elsabagh, Mengzhi Wang. The Involvement of Gut Microbiota and Their Key Metabolites in Regulating Fetal Development via the Gut–Placental Axis. Cellular Reprogramming 2026; 28(3) doi: 10.1177/21524971261450000
|
| 24 |
Feng Zhu, Shudan Zheng, Mei Zhao, Fan Shi, Lihong Zheng, Haiqiang Wang. The regulatory role of bile acid microbiota in the progression of liver cirrhosis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1214685
|
| 25 |
Nicolas Richard, Guillaume Savoye, Mathilde Leboutte, Asma Amamou, Subrata Ghosh, Rachel Marion-Letellier. Crohn’s disease: Why the ileum?. World Journal of Gastroenterology 2023; 29(21): 3222-3240 doi: 10.3748/wjg.v29.i21.3222
|
| 26 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Viral Liver Disease and Intestinal Gut–Liver Axis. Gastrointestinal Disorders 2024; 6(1) doi: 10.3390/gidisord6010005
|
| 27 |
Hui Zhang, Xiao Cui, Wei Liu, Zheng Xiang, Ji-Feng Ye. Regulation of intestinal microflora and metabolites of Penthorum chinense Pursh on alcoholic liver disease. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1331956
|
| 28 |
Satyam Yadav, Ranjeet Kumar. Gut Microbiota and the Gut-liver Axis in Hepatocellular Carcinoma: A Comprehensive Review of Pathogenesis and Therapeutic Strategies. Anti-Cancer Agents in Medicinal Chemistry 2025; 25(17) doi: 10.2174/0118715206364200250304034753
|
| 29 |
Anuradha Tyagi, Vinay Kumar. The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health. World Journal of Microbiology and Biotechnology 2025; 41(7) doi: 10.1007/s11274-025-04395-7
|
| 30 |
Kimia Mohammadhasani, Mohammad Vahedi Fard, Ali Mottaghi Moghaddam Shahri, Zahra Khorasanchi. Polyphenols improve non‐alcoholic fatty liver disease via gut microbiota: A comprehensive review. Food Science & Nutrition 2024; 12(8) doi: 10.1002/fsn3.4178
|
| 31 |
Shruti Bhargava, Zhuangting Rao, Raymond Vanholder, Frank Tacke, Heidi Noels, Vera Jankowski, Juliane Hermann, Joachim Jankowski. The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney: A systematic review. Molecular Metabolism 2026; 103 doi: 10.1016/j.molmet.2025.102295
|
| 32 |
Vinay Jahagirdar, Mohammed Faisal Habeeb, Anand V. Kulkarni. Antimicrobial Resistance in Cirrhosis. Current Hepatology Reports 2024; 23(3) doi: 10.1007/s11901-024-00654-7
|
| 33 |
Russell R. Fling, Timothy R. Zacharewski. Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(22) doi: 10.3390/ijms222212431
|
| 34 |
Yi-Zhen Han, Bo-Xuan Du, Xing-Yu Zhu, Yang-Zhi-Yuan Wang, Hui-Juan Zheng, Wei-Jing Liu. Lipid metabolism disorder in diabetic kidney disease. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1336402
|
| 35 |
Yuanqing Zhu, Wenkang Gao, Mingjian Cheng, Xuyang li, Kailin Cai, Liuying Chen, Huikuan Chu. Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis. Cellular and Molecular Life Sciences 2026; 83(1) doi: 10.1007/s00018-026-06098-0
|
| 36 |
Yu Zhang, Hongbing Xie, Lirong Wang, Jianhe Hu, Lei Wang, Shouping Zhang. Effect of Weaning at 21 Days of Age on the Content of Bile Acids in Chyme of Cecum. Animals 2022; 12(16) doi: 10.3390/ani12162138
|
| 37 |
Yanfang Zheng, Jiaying Chen, Ying Zhang, Huaying Guan, Shan Deng, Dennis Chang, Yitao Wang, JinJian Lu, Xian Zhou, Qin Xie, Jianyuan Song, Mingqing Huang. Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease. Phytotherapy Research 2025; 39(5) doi: 10.1002/ptr.8474
|
| 38 |
Tao Wang, Xu-Jiong Li, Ling-Hao Qin, Xue Liang, Huan-Huan Xue, Jing Guo, Shi-Fei Li, Li-Wei Zhang. Better detoxifying effect of ripe forsythiae fructus over green forsythiae fructus and the potential mechanisms involving bile acids metabolism and gut microbiota. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.987695
|
| 39 |
Xu Xu, Xiao Wei, Xiaolin Yang, Shaofang Lin. Inflammaging in geriatric liver disease: Mechanistic insights and therapeutic frontiers. Mechanisms of Ageing and Development 2026; 231 doi: 10.1016/j.mad.2026.112165
|
| 40 |
Morgane M. Thibaut, Justine Gillard, Adeline Dolly, Martin Roumain, Isabelle A. Leclercq, Nathalie M. Delzenne, Giulio G. Muccioli, Laure B. Bindels. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice. Cancers 2021; 13(24) doi: 10.3390/cancers13246389
|
| 41 |
Yulin Guo, Feng Cao, Fei Li. Impacts of pancreatic exocrine insufficiency on gut microbiota. Journal of Zhejiang University-SCIENCE B 2024; 25(4) doi: 10.1631/jzus.B2300070
|
| 42 |
Miguel Suárez, Raquel Martínez, Ana María Torres, Antonio Ramón, Pilar Blasco, Jorge Mateo. Personalized Risk Assessment of Hepatic Fibrosis after Cholecystectomy in Metabolic-Associated Steatotic Liver Disease: A Machine Learning Approach. Journal of Clinical Medicine 2023; 12(20) doi: 10.3390/jcm12206489
|
| 43 |
Aycan Gundogdu, Muzaffer Arikan, Alican Ulas, Seda Sevilay Koldaş, Gulfem Ece. From dysbiosis to therapy: Shared gut microbial signatures and targeted interventions across liver, heart and brain disorders. Next Research 2025; 2(4) doi: 10.1016/j.nexres.2025.100846
|
| 44 |
Yanqi Li, Ying Fan, Yashi Zhang, Aizhen Zong, Fangling Du, Tongcheng Xu. Stachyose Attenuates Hepatic Cholesterol Deposition in Nonalcoholic Fatty Liver Mice via Gut Microbiota-Driven Bile Acid Profile Remodeling. Journal of Agricultural and Food Chemistry 2025; 73(41) doi: 10.1021/acs.jafc.5c09242
|
| 45 |
Yang Chen, Zhenglian Wang, Yixuan Zeng, Xuqiu Xie, Linquan Liu, Yan Qian. Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune−mediated liver diseases. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1708826
|
| 46 |
María Luisa Ojeda, Fátima Nogales, José A. Carrasco López, María del Carmen Gallego-López, Olimpia Carreras, Ana Alcudia, Eloísa Pajuelo. Microbiota-Liver-Bile Salts Axis, a Novel Mechanism Involved in the Contrasting Effects of Sodium Selenite and Selenium-Nanoparticle Supplementation on Adipose Tissue Development in Adolescent Rats. Antioxidants 2023; 12(5) doi: 10.3390/antiox12051123
|
| 47 |
Saraswathy Sivaprasadan, K.N. Anila, Anju S. Nair, Krishnanunni Nair, Shweta Mallick, S.T. Binoj, Ramachandran Narayana Menon, G. Unnikrishnan, Dinesh Balakrishnan, Lalitha Biswas, Raaj Kumar Praseedom, Bipin Kumar G. Nair, Sudhindran Surendran. Can the use of synbiotics following live donor liver transplantation alter the microbiota milieu, decrease infection rates and improve graft survival?. Medical Hypotheses 2025; 205 doi: 10.1016/j.mehy.2025.111816
|
| 48 |
Rong-Jing Qie, Jiang-Bo Qin, Hong-Yu Wu, Zhong-Hao Ji. Key messengers in the gut-nose axis: mechanisms of gut microbial metabolites in the immunomodulation of allergic rhinitis. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1796775
|
| 49 |
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential. Dokazatel'naya gastroenterologiya 2022; 11(4) doi: 10.17116/dokgastro20221104165
|
| 50 |
Haoyu Bian, Liping Zhang, Yupu Yao, Fuqi Lv, Jiaoyang Wei. How traditional Chinese medicine can prevent recurrence of common bile duct stones after endoscopic retrograde cholangiopancreatography?. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1363071
|